性做久久久久久坡多野结衣-性做久久久久久久久浪潮-性欲影院-性影院-国产精品线路一线路二-国产精品兄妹在线观看麻豆

產(chǎn)品展廳收藏該商鋪

您好 登錄 注冊

當前位置:
美國布魯克海文儀器公司>技術(shù)文章>Nanobrook Omni測量應(yīng)用案例-15

技術(shù)文章

Nanobrook Omni測量應(yīng)用案例-15

閱讀:237          發(fā)布時間:2018-6-19

文獻名: Lipidic Nanoparticles Comprising Phosphatidylinositol Mitigate Immunogenicity and Improve Efficacy of Recombinant Human Acid Alpha-Glucosidase in a Murine Model of Pompe Disease

 

作者Jennifer L.Schneider, Robert K.Dingman, Sathy V.Balu-Iyer 

Department of Pharmaceutical Sciences, University at Buffalo, The State University of New York, Buffalo, New York 14214

 

摘要:Enzyme replacement therapy with recombinant human acid α-glucosidase (rhGAA) is complicated by the formation of anti-rhGAA antibodies, a short circulating half-life, instability in the plasma, and limited uptake into target tissue. Previously, we have demonstrated that phosphatidylinositol (PI) containing liposomes can reduce the immunogenicity and extend plasma survival of factor VIII (FVIII) in a mouse model of hemophilia A. In this article, we investigate the ability of PI liposomes to be used as a delivery vehicle to overcome the issues that complicate therapy with rhGAA. In a murine model of Pompe disease, administration of PI-rhGAA mitigated the immunogenicity of rhGAA, resulting in a significantly lower formation of anti-rhGAA antibodies. PI-rhGAA also showed minimal improvements to the pharmacokinetic parameters and efficacy measures compared to free rhGAA. Overall, these data suggest that PI-rhGAA may have the potential to be a useful therapeutic option for improving the treatment of Pompe disease.

收藏該商鋪

登錄 后再收藏

提示

您的留言已提交成功!我們將在第一時間回復(fù)您~

對比框

產(chǎn)品對比 產(chǎn)品對比 聯(lián)系電話 二維碼 意見反饋 在線交流

掃一掃訪問手機商鋪
010-62081908
在線留言
主站蜘蛛池模板: 绥中县| 德阳市| 满城县| 繁峙县| 嘉荫县| 江门市| 瓮安县| 大庆市| 忻州市| 蛟河市| 渝北区| 丰顺县| 敖汉旗| 勃利县| 奇台县| 海城市| 赤水市| 墨江| 平顶山市| 双流县| 汾阳市| 乌鲁木齐县| 云安县| 兴安县| 浦东新区| 永年县| 桐乡市| 镇江市| 宕昌县| 延安市| 贞丰县| 哈密市| 江西省| 新乡市| 南召县| 南丹县| 友谊县| 安顺市| 伊春市| 房山区| 涞源县|